News from CNBC Business
What is your interest today?
Tariffs
Investors
Ceo
Stock
Earnings
Shares
Stocks
Eqs
China
Nasdaq
Cet
Markets
Investment
Wall Street
Trade
Revenue
Nvidia
Tesla
Stock Market
Class Action
Securities
Economy
Bitcoin
Inflation
Us
Sales
Company
Trade War
Prices
Apple
Federal Reserve
Sp 500
Pvr
Crypto
Guidance
Interest Rates
Companies
Warren Buffett
Ipo
Amazon
Berkshire Hathaway
Shareholders
Federal Securities Laws
Walmart
Profit
Voting Rights
Investor
German Securities Trading Act
Trading
Securities Laws
Celebrities
Credit Card Debt
Customer Service
Subscription Rights
Personal Data
Junk Fees
Economic Sanctions
Geopolitical Risk
Alaska Energy Project
Ics
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Cnbc Business headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
CNBC Business • May 01, 2025
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS has raised its full-year earnings forecast to between $6 and $6.20 per share due to positive developments in its insurance sector, surpassing previous expectations.
Read Full Article →
CNBC Business • May 01, 2025
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, improving accessibility for patients on its drug plans and potentially increasing the treatment's market presence...
Read Full Article →